Dr. John P. Kelly, MD

  • Carson City, NV
  • Hematologist and oncologist
NPI1477512234PAC ID4183609019
Medicare services, 2024
1,086
Medicare patients, 2024
603
Part D claims, 2024
1,532
Clinical trials
1
Hospital affiliations
5
Practice address
1535 Medical Pkwy, Carson City, NV 89703
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Carson Tahoe Cancer Center - HOPD

Acute Care Hospital outpatient department · Carson City, Nevada

See all 11 affiliations

Find Dr. Kelly's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John P. Kelly is a hematologist and oncologist in Carson City, Nevada

Dr. Kelly practices at Carson Tahoe Cancer Center - HOPD in Carson City, Nevada.

Dr. Kelly's NPI, 1477512234, was assigned on March 21, 2006. Dr. Kelly graduated from Baylor College Of Medicine in 1979. Dr. Kelly holds Nevada license NV6376.

NPI and contact details
Medicare PAC ID
4183609019
NPI enumeration date
March 21, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
73
Medical school graduation
1979

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John P. Kelly practices at Carson Tahoe Cancer Center - HOPD in Carson City, Nevada

Dr. Kelly's primary practice is Carson Tahoe Cancer Center - HOPD, at 1535 Medical Pkwy, Carson City, NV 89703.

  • Carson Tahoe Cancer Center - HOPD
    1535 Medical Pkwy, Carson City, NV 89703

Source: Dmand AI Affiliation Data

Dr. John P. Kelly is affiliated with 9 sites of care and 2 medical groups

Dr. Kelly's primary practice is Carson Tahoe Cancer Center - HOPD in Carson City, Nevada. Dr. Kelly is also affiliated with Carson Tahoe Regional Medical Center. The medical group on file is Carson Tahoe Medical Group. Dmand AI also links Dr. Kelly to 4 more hospitals, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

See all 11 affiliations for Dr. Kelly

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. John P. Kelly's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelly practices, 9 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Carson Tahoe Cancer Center - HOPDAvailable with a free account
+8 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Kelly practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John P. Kelly is one of 67 hematologists and oncologists in Nevada

Hematology and oncology is Dr. Kelly's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kelly is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kelly's licenses on file in 2 states: Nevada and Texas.

Specialties and state licenses

  • Hematology and oncology, NevadaPrimaryLicense NV6376 · 1991 to 2027 · taxonomy 207RH0003X
  • Texas license1980 to 1995

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Kelly treats.

Hematologists and oncologists near Dr. Kelly

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

67hematologists and oncologists in Nevada
2hematologists and oncologists in Carson City

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John P. Kelly billed Medicare for 1,086 services in 2024

CMS data shows 1,086 Medicare services from Dr. Kelly across 7 procedure codes in 2024, for 603 Medicare patients. Medicare paid $93,256 for them. Every service was in an office.

Medicare services, 20241,086
Medicare patients603
Paid by Medicare$93,256
Procedure codes7

Dr. Kelly's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,1422024: 1,0865%

Dr. Kelly compared with the Nevada median for hematologists and oncologists, 2024

  • Dr. Kelly
  • Nevada median
Medicare services
1,086vs 19,90095% below
Medicare patients
603vs 603Close to median
Part D claims
1,295vs 79363% above

Medians across 67 hematologists and oncologists in Nevada with Dmand AI profiles that report each measure.

Dr. Kelly's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kelly

Need commercial claims for Dr. Kelly?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kelly and other hematologists and oncologists in Nevada.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John P. Kelly treated 603 Medicare patients in 2024, average age 76

CMS counts 603 Medicare patients who saw Dr. Kelly in 2024. The largest group is 75 to 84, with 284 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kelly's median patient age at 73, with 50% women.

Medicare patients, 2024603
Average age76
Average risk score1.65
Also on Medicaid5%

Dr. Kelly's Medicare patients by age, 2024

Dr. Kelly's Medicare patients by sex, 2024

  • Women29849%
  • Men30551%

Chronic conditions among Dr. Kelly's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure72%
  3. Cancer51%
  4. Arthritis43%
  5. Chronic kidney disease25%
  6. COPD24%
  7. Ischemic heart disease23%
  8. Diabetes22%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kelly's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women50%
  • Men50%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John P. Kelly wrote 1,532 Medicare Part D claims in 2024

In 2024, Dr. Kelly wrote 1,532 Medicare Part D claims for 294 patients. 73% of them were for generic drugs. CMS names the drug for 1,295 of them, across 40 drugs with 11 or more claims each, at $5,176,348 in total drug cost. In 2023, CMS named 1,134 claims across 29 drugs.

Part D claims, 20241,532
Drugs named by CMS40
Total drug cost$5.2M
Part D patients294

Dr. Kelly's Part D claims by kind of drug, 2024

  • Generic1,121 claims73%
  • Brand-name and other411 claims27%

Dr. Kelly's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kelly's Part D claims, 2024

  • Opioids8%128 of 1,532 claims
  • Antibiotics1%21 of 1,532 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,1342024: 1,29514%

Drugs named by CMS: 40 in 2024, 29 in 2023.

See all prescribing by Dr. Kelly

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John P. Kelly offers telehealth to Medicare patients

Dr. Kelly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kelly as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Kelly by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John P. Kelly has worked on 1 clinical trial

Dmand AI links Dr. Kelly to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Male and Breast Neoplasms.

Conditions in Dr. Kelly's trials

  • Breast Neoplasms, Male
  • Breast Neoplasms

Investigators on the most trials with Dr. Kelly

Recent clinical trials with Dr. Kelly

Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. John P. Kelly received $20,803 in industry payments from 2016 to 2025

CMS Open Payments shows 1,088 general payments to Dr. Kelly from 96 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,399.

General payments to Dr. Kelly by program year, 2016 to 2025

General payments to Dr. Kelly by kind, 2016 to 2025

$20.8Kin total
  • Food and beverage$19,79695%
  • Education$1,0065%

Companies that paid Dr. Kelly the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kelly

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. John P. Kelly has 1 award and honors on record

Dmand AI lists 1 award for Dr. Kelly, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Kelly

  1. 2013
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. John P. Kelly graduated from Baylor College Of Medicine

Dr. Kelly graduated from Baylor College Of Medicine in 1979. Dr. Kelly is a member of ASCO.

  1. Medical schoolBaylor College Of Medicine
  2. Board certified in internal medicineAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. John P. Kelly accepts plans from 14 insurance carriers

Dr. Kelly is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.

Plan types Dr. Kelly accepts, by number of carriers

  1. PPO8
  2. HMO6
  3. EPO5
  4. Medicare4
  5. POS4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. John P. Kelly's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John P. Kelly

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John P. Kelly's NPI number?

Dr. John P. Kelly's NPI number is 1477512234. It was assigned on March 21, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. John P. Kelly?

Dr. John P. Kelly is a hematologist and oncologist in Carson City, Nevada. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. John P. Kelly practice?

Dr. Kelly practices at 1535 Medical Pkwy, Carson City, NV 89703. Dr. Kelly's primary practice is Carson Tahoe Cancer Center - HOPD in Carson City, Nevada. Dmand AI also links Dr. Kelly to 4 hospitals, 2 group practices and clinics, 1 physician office and 1 medical group.

What is Dr. John P. Kelly's medical license number?

Dr. Kelly holds Nevada license NV6376, one of the licenses on file in 2 states.

Which states has Dr. John P. Kelly been licensed in?

Dmand AI has state licenses on file for Dr. Kelly in Nevada (1991 to 2027) and Texas (1980 to 1995).

Which hospitals is Dr. John P. Kelly affiliated with?

Dr. Kelly is affiliated with Carson Tahoe Regional Medical Center. Dmand AI links Dr. Kelly to 4 more hospitals.

What medical group is Dr. John P. Kelly part of?

Dr. Kelly is linked to Carson Tahoe Medical Group. Dmand AI links Dr. Kelly to 1 more medical group.

Does Dr. John P. Kelly accept Medicare?

Yes. CMS data shows Dr. Kelly billed Medicare for 1,086 services in 2024, and Dr. Kelly accepts Medicare assignment.

Does Dr. John P. Kelly offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Kelly as offering telehealth services.

How many Medicare patients does Dr. John P. Kelly see?

CMS counts 603 Medicare patients who saw Dr. Kelly in 2024, with an average age of 76.

Show 8 more questionsShow fewer questions

Is Dr. John P. Kelly board certified?

Yes. Dr. Kelly is board certified in internal medicine by the American Board of Internal Medicine.

What services does Dr. John P. Kelly bill to Medicare?

In 2024, Dr. Kelly's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, new patient (99204).

Where did Dr. John P. Kelly go to medical school?

Dr. Kelly graduated from Baylor College Of Medicine in 1979.

What drugs does Dr. John P. Kelly prescribe most?

In 2024 Medicare Part D data, Dr. Kelly's most prescribed drugs by claims were Anastrozole, Hydroxyurea and Abiraterone Acetate.

Has Dr. John P. Kelly received payments from drug or device companies?

CMS Open Payments shows $20,803 in general payments to Dr. Kelly from 96 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. John P. Kelly been practicing?

Dr. Kelly graduated from medical school in 1979, 47 years ago.

Does Dr. John P. Kelly do research?

Dr. Kelly has worked on 1 clinical trial.

What insurance does Dr. John P. Kelly accept?

Dr. Kelly is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Nevada by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)